Toxic RNAs containing expanded trinucleotide repeats are the cause of many neuromuscular disorders, one being myotonic dystrophy type 1 (DM1). DM1 is triggered by CTG-repeat expansion in the 3′-untranslated region of the <i>DMPK</i> gene, resulting in a toxic gain of RNA function through sequestration of MBNL1 protein, among others. Herein, we report the development of a relatively short miniPEG-γ peptide nucleic acid probe, two triplet repeats in length, containing terminal pyrene moieties, that is capable of binding rCUG repeats in a sequence-specific and selective manner. The newly designed probe can discriminate the pathogenic rCUG<sup>exp</sup> from the wild-type transcript and disrupt the rCUG<sup>exp</sup>–MBNL1 complex. The work pro...
Contains fulltext : 81075.pdf (publisher's version ) (Closed access)Myotonic dystr...
Myotonic dystrophy type 1 (DM1) is a dominant human neuromuscular disorder caused by a CTG repeat ex...
RNA is an important drug target, but it is difficult to design or discover small molecules that modu...
New discoveries showing the key role of RNAs in diseases such as cancer and neurodegenerative disord...
Mismatched base pairs are ubiquitous in more than 30 hereditary disorders whose origin can be traced...
Excluding the ribosome and riboswitches, developing small molecules that selectively target RNA is a...
Trinucleotide Repeat Expansion Disorders (TREDS) are ascribed to generational expansion of genomic r...
Altres ajuts: Obra Social "La Caixa"Myotonic Dystrophy type 1 (DM1) is an incurable neuromuscular di...
Myotonic dystrophy type 1 (DM1) is caused by DM protein kinase (DMPK) transcripts containing an expa...
Myotonic dystrophy type 1 (DM1) is a dominant human neuromuscular disorder caused by a CTG repeat ex...
A solid-phase DNA-encoded library (DEL) was studied for binding the RNA repeat expansion r(CUG)exp, ...
Myotonic Dystrophy type 1 (DM1) is a genetic disorder caused by an expansion of a (CTG)n repeat in t...
Single-agent, single-target therapeutic approaches are often limited by a complex disease pathobiolo...
Single-agent, single-target therapeutic approaches are often limited by a complex disease pathobiolo...
Single-agent, single-target therapeutic approaches are often limited by a complex disease pathobiolo...
Contains fulltext : 81075.pdf (publisher's version ) (Closed access)Myotonic dystr...
Myotonic dystrophy type 1 (DM1) is a dominant human neuromuscular disorder caused by a CTG repeat ex...
RNA is an important drug target, but it is difficult to design or discover small molecules that modu...
New discoveries showing the key role of RNAs in diseases such as cancer and neurodegenerative disord...
Mismatched base pairs are ubiquitous in more than 30 hereditary disorders whose origin can be traced...
Excluding the ribosome and riboswitches, developing small molecules that selectively target RNA is a...
Trinucleotide Repeat Expansion Disorders (TREDS) are ascribed to generational expansion of genomic r...
Altres ajuts: Obra Social "La Caixa"Myotonic Dystrophy type 1 (DM1) is an incurable neuromuscular di...
Myotonic dystrophy type 1 (DM1) is caused by DM protein kinase (DMPK) transcripts containing an expa...
Myotonic dystrophy type 1 (DM1) is a dominant human neuromuscular disorder caused by a CTG repeat ex...
A solid-phase DNA-encoded library (DEL) was studied for binding the RNA repeat expansion r(CUG)exp, ...
Myotonic Dystrophy type 1 (DM1) is a genetic disorder caused by an expansion of a (CTG)n repeat in t...
Single-agent, single-target therapeutic approaches are often limited by a complex disease pathobiolo...
Single-agent, single-target therapeutic approaches are often limited by a complex disease pathobiolo...
Single-agent, single-target therapeutic approaches are often limited by a complex disease pathobiolo...
Contains fulltext : 81075.pdf (publisher's version ) (Closed access)Myotonic dystr...
Myotonic dystrophy type 1 (DM1) is a dominant human neuromuscular disorder caused by a CTG repeat ex...
RNA is an important drug target, but it is difficult to design or discover small molecules that modu...